###begin article-title 0
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
rs5888 Variant of SCARB1 Gene Is a Possible Susceptibility Factor for Age-Related Macular Degeneration
###end article-title 0
###begin p 1
Conceived and designed the experiments: JZ NL PB PB JF AM JK EHS. Performed the experiments: JZ RR NL EHS. Analyzed the data: JZ JS FR JF AM JK JMR EHS. Contributed reagents/materials/analysis tools: JS PB GS JK JMR EHS. Wrote the paper: JZ JS FR EHS.
###end p 1
###begin p 2
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 170 196 170 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2 LOC387715/HTRA1locus</italic>
###xml 319 327 319 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFHY402H</italic>
###xml 332 354 332 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715 A69S (ARMS2)</italic>
###xml 497 503 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 907 910 907 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 915 920 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 971 977 971 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1592 1598 1592 1598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1600 1601 1600 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
###xml 796 804 <span type="species:ncbi:9606">patients</span>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
Major genetic factors for age-related macular degeneration (AMD) have recently been identified as susceptibility risk factors, including variants in the CFH gene and the ARMS2 LOC387715/HTRA1locus. Our purpose was to perform a case-control study in two populations among individuals who did not carry risk variants for CFHY402H and LOC387715 A69S (ARMS2), called "study" individuals, in order to identify new genetic risk factors. Based on a candidate gene approach, we analyzed SNP rs5888 of the SCARB1 gene, coding for SRBI, which is involved in the lipid and lutein pathways. This study was conducted in a French series of 1241 AMD patients and 297 controls, and in a North American series of 1257 patients with advanced AMD and 1732 controls. Among these individuals, we identified 61 French patients, 77 French controls, 85 North American patients and 338 North American controls who did not carry the CFH nor ARMS2 polymorphisms. An association between AMD and the SCARB1 gene was seen among the study subjects. The genotypic distribution of the rs5888 polymorphism was significantly different between cases and controls in the French population (p<0.006). Heterozygosity at the rs5888 SNP increased risk of AMD compared to the CC genotypes in the French study population (odds ratio (OR) = 3.5, CI95%: 1.4-8.9, p<0.01) and after pooling the 2 populations (OR = 2.9, 95% CI: 1.6-5.3, p<0.002). Subgroup analysis in exudative forms of AMD revealed a pooled OR of 3.6 for individuals heterozygous for rs5888 (95% CI: 1.7-7.6, p<0.0015). These results suggest the possible contribution of SCARB1, a new genetic factor in AMD, and implicate a role for cholesterol and antioxidant micronutrient (lutein and vitamin E) metabolism in AMD.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Vingerling1">[1]</xref>
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Seddon1">[2]</xref>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Tomany1">[3]</xref>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Seddon4">[9]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Seddon5">[10]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Klein1">[14]</xref>
###xml 515 518 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Gold1">[15]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Fagerness1">[26]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Maller1">[64]</xref>
###xml 826 829 826 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Seddon3">[8]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Souied2">[27]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Delcourt1">[33]</xref>
Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the elderly population in Europe and United States [1], [2]. Identification of risk factors is of major importance for the understanding of the origins of the disorder and for establishing strategies to prevent AMD. Risk factors for AMD are both environmental [3]-[9] and genetic [10]-[14]. Over the past few years, several single nucleotide polymorphisms (SNPs) have been associated with AMD, including variants in the CFH and ARMS2 genes [15]-[26], [64]. The association between these polymorphisms and AMD risk suggests a pathway of inflammation and oxidation in AMD. Besides these pathways, several lines of evidence suggest a strong role of antioxidant micronutrients (xanthophylls, vitamin E and vitamin C) and lipids in AMD [8], [27]-[33].
###end p 4
###begin p 5
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Jian1">[34]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Rigotti1">[37]</xref>
###xml 405 411 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Reboul1">[38]</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-During1">[39]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Borel1">[40]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-vanLeeuwen1">[42]</xref>
###xml 888 894 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Ritsch1">[43]</xref>
###xml 1030 1034 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Roberts1">[48]</xref>
###xml 1089 1095 1089 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 610 615 <span type="species:ncbi:9606">human</span>
###xml 828 833 <span type="species:ncbi:9606">human</span>
###xml 1162 1170 <span type="species:ncbi:9606">patients</span>
Our purpose was to assess candidate genes and polymorphisms involved in the lipid pathway among individuals harboring non-risk alleles for CFH and ARMS2. The SCARB1 gene which encodes SRB1, a multiligand cell surface receptor, is known to mediate selective cholesterol uptake, and cholesterol efflux [34]-[37], and was regarded as an attractive candidate gene. Furthermore, recent studies have shown that SCARB1 is also involved in uptake of vitamin E and lutein giving further support to a possible role of SCARB1 in AMD [38], [39]. In fact, the xanthophyll, lutein, is recovered at high concentration in the human macula lutea and has been associated with the risk of AMD, and vitamin E, the main lipophilic antioxidant, is suspected to prevent oxidation of polyunsaturated fatty acids recovered at high concentrations in the human retina [40]-[42]. Several studies have suggested that SCARB1 genotypes for the rs5888 synonymous SNP may play a role in cholesterol homeostasis and is associated with cardiovascular diseases [43]-[48]. Herein, we report a possible association between the SCARB1 rs5888 SNP and AMD in a subgroup of French and North American AMD patients in a case-control study.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 410 417 402 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t001">Table 1</xref>
The French cohort consisted of 1241 cases (92% exudative AMD, 5.2% geographic atrophy, 2.8% early or intermediate AMD) and 297 controls. The mean+/-SD age at AMD diagnosis was 78.8+/-7.5 years. The North American cohort consisted of 1732 advanced AMD cases (72.4% exudative AMD, 27.6% geographic atrophy) and 1257 controls. All subjects were Caucasian. The mean+/-SD age at AMD diagnosis was 80.3+/-6.5 years (Table 1).
###end p 7
###begin title 8
Non-genetic characteristics of the entire French and North American populations.
###end title 8
###begin p 9
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t002">Table 2</xref>
###xml 183 192 183 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH Y402H</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 483 490 483 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t002">Table 2</xref>
###xml 526 532 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 729 737 729 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT vs CC</sub>
###xml 936 944 936 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT vs CC</sub>
###xml 983 991 983 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT vs CC</sub>
###xml 473 481 <span type="species:ncbi:9606">patients</span>
The genotype distributions of the rs1061170, rs10490924 and rs5888 SNPs within the CFH, ARMS2 and SCARB1 genes, respectively, are shown in Table 2. The genotypic distributions of the CFH Y402H and ARMS2 SNPs were significantly different between cases and controls in both the French and North American series (p<0.0001 for both groups). For rs5888 genotypes, regardless of CFH or ARMS2 genotypes, no significant association was found in the entire French population of AMD patients (Table 2). However, the distribution of the SCARB1 rs5888 genotype was significantly different in the North American AMD population compared to controls (p<0.004): CT heterozygotes were at increased risk of AMD compared to CC subjects (adjusted ORCT vs CC = 1.4, 95%CI 1.0-1.8), TT did not significantly differ from CC (adjusted OR = 1.2 CI95% 0.9-1.7).Similar results were obtained after pooling the French and the North American population: adjusted ORCT vs CC = 1.3, 95%CI: 1.0-1.7) and adjusted ORTT vs CC = 1.2, 95%CI 0.9-1.7. Odds Ratio were adjusted for non genetic confounders: age, gender and smoking status.
###end p 9
###begin title 10
Genotype distributions among the entire French and North American populations.
###end title 10
###begin p 11
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
P values: global chi2 test with 2 degrees of freedom for comparison of genotype distribution between cases and controls.
###end p 11
###begin p 12
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 92 99 92 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t003">Table 3</xref>
###xml 105 113 105 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007341.s001">Table S1</xref>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 511 519 511 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CT vs CC</sub>
###xml 823 830 823 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t004">Table 4</xref>
Characteristics of subjects carrying no risk alleles at the CFH and ARMS2 loci are shown in Table 3 (and Table S1). In the French population, genotypic distribution of the SCARB1 polymorphism was significantly (p<0.01) different between cases and controls: CT heterozygotes compared to CC subjects were at increased risk of AMD. (adjusted OR 3.5, 95%CI1.4-8.9). In the North American population, we observed a suggested increased risk of AMD associated with heterozygocity at the rs5888 (global test p<0.09): ORCT vs CC = 2.5; 95%CI 1.1-5.7. Similar results were obtained when pooling French and North American populations (global test, p<0.002), in that CT individuals were at increased risk of AMD compared to CC genotypes: adjusted OR = 2.9; 95%CI1.6-5.3 while TT subjects did not significantly differ from CC subjects (Table 4).
###end p 12
###begin title 13
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
Non-genetic characteristics of the French and North American populations with no risk alleles for CFH and ARMS2.
###end title 13
###begin title 14
###xml 20 45 20 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">for rs5888 of SCARB1 gene</italic>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Adjusted Odds ratio for rs5888 of SCARB1 gene in patients with no risk alleles for CFH and ARMS2.
###end title 14
###begin p 15
Adjustment for non genetic confounders: age, sex, and cigarette smoking.
###end p 15
###begin p 16
###xml 4 11 4 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t004">table 4</xref>
For table 4, OR are estimated by genotype (CT vs CC and TT vs CT) but the p values are global p values (with 2 degrees of freedom) for estimates a global effect of genotype (is at least one of the genotypes (CT or TT) significantly associated with increased rik of AMD).
###end p 16
###begin p 17
*Interaction with center; p<0.29, interaction with sex (in pooled population), p<0.48.
###end p 17
###begin p 18
Sample size: France: 61 cases and 72 controls - USA: 56 cases and 160 controls.
###end p 18
###begin p 19
In exudative AMD subgroups (Cases: n = 105, 55 French and 50 American; controls: n = 415, 77 French and 338 American), adjusted OR after pooling both populations for CT heterozygous individuals was: OR = 3.6, 95%CI: 1.7-7.6, p<0.0015.
###end p 19
###begin title 20
Discussion
###end title 20
###begin p 21
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
Here we report for the first time a possible association between a polymorphism in the SCARB1 gene and AMD, in two distinctly different Caucasian populations.
###end p 21
###begin p 22
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Haddad1">[49]</xref>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Gold1">[15]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Fagerness1">[26]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Maller1">[64]</xref>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Shuler1">[50]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Schaumberg1">[51]</xref>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
###xml 705 713 <span type="species:ncbi:9606">patients</span>
###xml 827 835 <span type="species:ncbi:9606">patients</span>
###xml 865 873 <span type="species:ncbi:9606">patients</span>
AMD is a multifactorial disorder including both environmental and genetic factors. Among the long list of genes potentially involved in AMD [49], two major genes have been recently associated to AMD: CFH and ARMS2[15]-[26], [64]. Because, double homozygosity for the CFH and ARMS2 risk alleles account for more than 50% in the pathology of AMD [50], [51], we hypothesized that candidate gene screening in a subgroup of AMD patients and controls homozygous for CFH and ARMS2 wild-type alleles may help in identifying novel and independent genetic risk factors. One limit of our study is the sample size of our populations without the CFH and/or the ARMS2 at-risk alleles. Only 61/1241 (4.9%) of AMD French patients and 85/1732 (4.9%) of American AMD did not carry one of these at-risk alleles. Thus, it requires large series of patients in order to assure that some patients without the CFH and/or the ARMS2 at-risk alleles are present in the final sample.
###end p 22
###begin p 23
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 610 613 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 1018 1023 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 1083 1089 1083 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 837 845 <span type="species:ncbi:9606">patients</span>
###xml 942 950 <span type="species:ncbi:9606">patients</span>
###xml 1229 1237 <span type="species:ncbi:9606">patients</span>
Heterozygosity for the rs5888 SNP of the SCARB1 gene (CT) may be associated with an increased risk of AMD in the French and North American populations, respectively. Nevertheless, our findings have to be interpreted very cautiously. Heterozygosity was found significantly associated to AMD in wild-type individuals for CFH and ARMS2 in the French group (p<0.01), and in the same direction but not significant in the North American population (p<0.09). Heterozygosity at the rs5888 was also found to be significantly associated with AMD when all North American individuals, regardless of their genotypes at the CFH and ARMS2 loci, were considered (p<0.004), but not in the French population. This discrepancy might be explained by the low number of French controls, compared to the North-American sample. However the number of French AMD patients and controls (respectively 1241 and 297) was evaluated in order to obtain similar number of AMD patients and controls in wild-types groups with no risk alleles for CFH and ARMS2 (respectively 61 and 77). An association between rs5888 of SCARB1 and the exudative type of AMD was observed (OR: 3.6, 95%CI: 1.7-7.6; p<0015). We enrolled a large number of exudative forms of AMD because patients with neovascular AMD are most often referred to our specialized retina departments than atrophic forms of AMD.
###end p 23
###begin p 24
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Schick1">[52]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Swaroop1">[53]</xref>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Jian1">[34]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Rigotti1">[37]</xref>
###xml 378 384 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-RodrguezEsparragn1">[44]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Acton2">[45]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Roberts1">[48]</xref>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-RodrguezEsparragn1">[44]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Snow1">[54]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Tan1">[56]</xref>
###xml 928 934 928 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 987 991 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Duncan1">[57]</xref>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Huang1">[58]</xref>
###xml 1108 1112 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Fazio1">[59]</xref>
###xml 1145 1151 1145 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1211 1215 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Reboul2">[60]</xref>
###xml 1573 1576 1573 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Seddon3">[8]</xref>
###xml 1578 1582 1578 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-AgeRelated3">[61]</xref>
###xml 1715 1719 1715 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Delcourt1">[33]</xref>
###xml 1721 1725 1721 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Borel1">[40]</xref>
###xml 1727 1731 1727 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-AgeRelated2">[41]</xref>
###xml 1733 1739 1733 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1993 1999 1993 1999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 2162 2166 2162 2166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Ritsch1">[43]</xref>
###xml 2413 2418 2413 2418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 2471 2475 2471 2475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Fritsche1">[62]</xref>
###xml 2526 2532 2526 2532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 2800 2806 2800 2806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 2816 2820 2816 2820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Hsu1">[63]</xref>
###xml 3150 3156 3150 3156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 3260 3264 3260 3264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Ritsch1">[43]</xref>
###xml 2545 2553 <span type="species:ncbi:9606">patients</span>
###xml 2557 2565 <span type="species:ncbi:9606">patients</span>
###xml 2572 2580 <span type="species:ncbi:9606">patients</span>
###xml 2590 2598 <span type="species:ncbi:9606">patients</span>
###xml 2655 2663 <span type="species:ncbi:9606">patients</span>
SCARB1 gene is located in 12q24.31, in a region of interest pointed by linkage analysis [52], [53]. SCARB1 gene encodes a multiligand cell surface receptor that mediates selective cholesterol uptake, and cholesterol efflux [34]-[37]. Reverse cholesterol transport, is a major pathway for the clearance of excess cholesterol from the body. Several studies have reported that the SCARB1 rs5888 SNP is associated with the development of coronary heart disease [44], and lipid profile [45]-[48]. Indeed, epidemiological studies in Caucasian populations have shown that the rs5888 is associated with increased HDL cholesterol and lower LDL cholesterol, and rs5888 has been reported to be associated with a greater risk of developing coronary heart disease in males [44]. Because AMD and cardiovascular diseases share common pathways [54]-[56], we decided to analyze genes involved in lipid homeostasis. Furthermore, it is known that SCARB1 is also expressed in the retinal pigment epithelium [57], and could interact with APOE, another gene which some groups but not all have reported to be involved in AMD [58], [59]. Besides the pathway of lipids, SCARB1 is also involved in the metabolism of lutein and vitamin E [60]. Lutein, obtained from foods, is a member of the carotenoid family, more specifically the xanthophyll family. Lutein protects the photoreceptors against light-initiated oxidative damage. Furthermore, epidemiologic studies based on diet questionnaires or serum levels of lutein revealed that high levels of lutein are associated with a decreased risk of AMD [8], [61]. Vitamin E acts as an antioxidant, protecting the retina against oxidative stress, with possible preventive and therapeutic effects [33], [40], [41]. SCARB1 is involved in the metabolism of three key molecules involved in the etiology of AMD: cholesterol, lutein and vitamin E, all supported by fundamental and epidemiological studies. For these reasons based on gene function and gene location, we considered SCARB1 as a good candidate gene for AMD. The greater risk of AMD found in CT individuals heterozygous at rs5888 has already been reported in peripheral arterial disease [43]. The rs5888 SNP is a coding-synonymous polymorphism (A350A). This polymorphism may nevertheless be in linkage disequilibrium with a functional sequence change as recently demonstrated with the identification of the rs10490924 polymorphism in the ARMS2 gene which results in instability of the transcript [62]. To evaluate this hypothesis, we sequenced the 13 SCARB1 exons (in 8 patients: 3 patients TT, 2 patients CC and 3 patients CT) and 200 kb of the 5'UTR in 92 wild-type individuals patients and controls, but we did not found any anomalies in the gene sequence, neither insertions or deletions such as the one described in the SCARB1 promotor [63]. The relatively small sample size in some of the subgroup analyses could also explain some of the findings. On the other hand, it is also possible that the rs5888 polymorphism has a functional effect through a mechanism involving splicing regulatory system. From this point of view it is worth noting that it has been shown that SCARB1 mRNA expression is significantly decreased in heterozygous individuals compared to homozygous CC or TT [43]. "A dominant-negative effect can be suggested." Further studies will hopefully bring insights into this intriguing question.
###end p 24
###begin p 25
In conclusion, our results suggest that the SCARB1 polymorphism is associated with AMD. This genetic finding is consistent with basic and epidemiological studies underlying the role of cholesterol, lutein and vitamin E in AMD. Additional studies including correlations with serum analysis and larger samples sizes are needed to confirm this finding.
###end p 25
###begin title 26
Methods
###end title 26
###begin title 27
French Populations
###end title 27
###begin title 28
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 28
###begin p 29
###xml 206 211 <span type="species:ncbi:9606">human</span>
Written informed consent was obtained, as required by the French bioethical legislation and local ethic committee (CCPPRB Henri Mondor), in agreement with the Declaration of Helsinki for research involving human subjects.
###end p 29
###begin p 30
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
###xml 334 339 <span type="species:ncbi:9606">women</span>
###xml 343 346 <span type="species:ncbi:9606">men</span>
###xml 624 632 <span type="species:ncbi:9606">Patients</span>
A total of 1241 French AMD patients were recruited in 4 French Ophthalmologic Centres, at the Ophthalmology Eye Clinic of Creteil in collaboration with the Pellegrin Hospital, the Quinze-Vingts Hospital and the Centre of Imaging and Laser of Paris, between November 2005 and July 2007. Inclusion criteria of the AMD patients were (1) women or men aged 55 or older, and (2) with exudative AMD, atrophic AMD or with early or intermediate AMD (also called Aged-Related Maculopathy) in at least one eye. Exclusion criteria were presence of other retinal disease (e.g. diabetic retinopathy, high myopia, or macular dystrophies). Patients underwent a complete ophthalmologic examination including best corrected visual acuity measurement, fundus examination, and retinal photographs. Fluorescein angiography (Topcon 50IA camera, Tokyo, Japan)- and if needed indocyanine green angiography (HRA, Heidelberg, Germany)- and Optical Coherence Tomography (Carl Zeiss Meditec, Inc) were performed. A questionnaire about medical history and smoking was completed.
###end p 30
###begin title 31
Controls
###end title 31
###begin p 32
###xml 22 27 <span type="species:ncbi:9606">women</span>
###xml 31 34 <span type="species:ncbi:9606">men</span>
A total of 297 French women or men over 55 years with a normal fundus examination and a normal aspect of fundus photography were also recruited at the Ophtalmology Eye Clinic of Creteil between 2002 and 2008. Information about their medical history including smoking, was obtained.
###end p 32
###begin title 33
Genotyping Methods
###end title 33
###begin p 34
###xml 140 146 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 154 157 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 168 173 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 381 385 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Leveziel1">[24]</xref>
Genomic DNA was extracted from 10 mL blood leukocytes using the Illustra(R) kit according to the manufacturer protocol (GE Healthcare). The SCARB1 rs5888 CFH Y402H and ARMS2 rs10490924 SNPs were genoyped by quantitative PCR allelic discrimination using reagents and conditions from Custom Taqman SNP Genotyping Assays (Applera Corp., France), using ABI 7900HT (Applied Biosystems) [24].
###end p 34
###begin title 35
North American Populations
###end title 35
###begin title 36
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 36
###begin p 37
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Maller1">[64]</xref>
###xml 295 302 295 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t001">Table 1</xref>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Subjects and methods of diagnosis and enrollment have been previously described [64]. All patients had advanced age-related macular degeneration, either exudative or geographic atrophy, and diagnosis was based on ocular examination and fundus photography. They were all Caucasian and unrelated (Table 1).
###end p 37
###begin title 38
Controls
###end title 38
###begin p 39
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007341-Maller1">[64]</xref>
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t001">Table 1</xref>
Caucasian individuals without AMD who were unrelated to the cases and to other controls were enrolled. Absence of AMD was based on ocular examination and grading of fundus photographs [64] (Table 1). All cases and controls signed a written informed consent form.
###end p 39
###begin title 40
Genotyping Methods
###end title 40
###begin p 41
DNA samples were evaluated for the rs5888 SNP using either the Affymetrix 6.0 platform as part of our genome-wide association study (under review) or the Sequenom platform. Genotyping was performed at the Broad Institute in Cambridge, MA, USA.
###end p 41
###begin title 42
Statistical Analysis
###end title 42
###begin p 43
###xml 297 298 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Hardy-Weinberg assumption was assessed by the standard method comparing the observed numbers of subjects in different genotype categories with the expected number under Hardy-Weinberg equilibrium for the estimated allele frequency, and testing with a Pearson goodness-of-fit statistic with the chi2 with 1 degree of freedom.
###end p 43
###begin p 44
###xml 105 112 103 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007341-t001">table 1</xref>
chi2 test was used to compare categorical allelic and genotype distributions between cases and controls (table 1). General linear models were used to compare means between cases and controls. Logistic regression models were used to estimated odds ratio (OR) with 95% confidence interval (95%CI) for AMD risk. OR's were adjusted for age, gender and smoking status. Significance levels were set at p<0.05. Analyses were performed with the SAS software release 9.01 (SAS Institute INC, Cary, NC).
###end p 44
###begin p 45
###xml 204 205 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Homogeneity between the 2 populations was tested by introduction of interaction terms with study center in the models (1rst test), by Breslow-day Test for homogeneity of the odds ratio (2nd test) and by I2 ( =  % of heterogeneity). I2 has been estimated by the software Review Manager 5. I2 and Breslow-Day test have been made without adjustment.
###end p 45
###begin title 46
Supporting Information
###end title 46
###begin p 47
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Genotype distribution for SCARB1 (rs5888) in the French and North American individuals with no risk alleles for CFH (rs1061170) and ARMS2 (rs10490924). P values: global chi2 test with 2 degrees of freedom for comparison of genotype distribution between cases and controls.
###end p 47
###begin p 48
(0.03 MB DOC)
###end p 48
###begin p 49
Click here for additional data file.
###end p 49
###begin p 50
J.F. Korobelnik, S.Y. Cohen, J.A. Sahel, J. Dumas, P. Ledudal.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
The prevalence of age-related maculopathy in the Rotterdam Study.
###end article-title 52
###begin article-title 53
Epidemiology of age-related macular degeneration.
###end article-title 53
###begin article-title 54
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
###end article-title 54
###begin article-title 55
The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.
###end article-title 55
###begin article-title 56
Genetic Factors in AMD Study. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation.
###end article-title 56
###begin article-title 57
Risk factors for age-related macular degeneration: Pooled findings from three continents.
###end article-title 57
###begin article-title 58
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3.
###end article-title 58
###begin article-title 59
Dietary carotenoids, vitamins A, C, and E and advanced age-related macular degeneration. A multicenter study.
###end article-title 59
###begin article-title 60
###xml 81 86 <span type="species:ncbi:9606">women</span>
A prospective study of cigarette smoking and age-related macular degeneration in women.
###end article-title 60
###begin article-title 61
Familial aggregation of age-related maculopathy.
###end article-title 61
###begin article-title 62
A genome-wide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions.
###end article-title 62
###begin article-title 63
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.
###end article-title 63
###begin article-title 64
Further evidence for an association of ABCR alleles with age-related macular degeneration.
###end article-title 64
###begin article-title 65
Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q.
###end article-title 65
###begin article-title 66
AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.
###end article-title 66
###begin article-title 67
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 67
###begin article-title 68
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 68
###begin article-title 69
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 69
###begin article-title 70
A common haplotype in the complement regulatory gene factor H HF1/CFH) predisposes individuals to age-related macular degeneration.
###end article-title 70
###begin article-title 71
Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age related macular degeneration.
###end article-title 71
###begin article-title 72
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
###end article-title 72
###begin article-title 73
Susceptibility genes for age-related maculopathy on chromosome 10q26.
###end article-title 73
###begin article-title 74
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
###end article-title 74
###begin article-title 75
PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.
###end article-title 75
###begin article-title 76
###xml 15 24 15 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH Y402H</italic>
###xml 29 43 29 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715 A69S</italic>
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
###end article-title 76
###begin article-title 77
Variation near complement factor I is associated with risk of advanced AMD.
###end article-title 77
###begin article-title 78
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.
###end article-title 78
###begin article-title 79
Genetic association of apolipoprotein E with age-related macular degeneration.
###end article-title 79
###begin article-title 80
Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20.
###end article-title 80
###begin article-title 81
Dietary fat and risk for advanced age-related macular degeneration.
###end article-title 81
###begin article-title 82
Progression of age-related macular degeneration: Association with dietary fat, transunsaturated fat, nuts, and fish intake.
###end article-title 82
###begin article-title 83
Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration. The US twin study of age-related macular degeneration.
###end article-title 83
###begin article-title 84
Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age.
###end article-title 84
###begin article-title 85
Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors.
###end article-title 85
###begin article-title 86
Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux.
###end article-title 86
###begin article-title 87
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.
###end article-title 87
###begin article-title 88
The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.
###end article-title 88
###begin article-title 89
Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte.
###end article-title 89
###begin article-title 90
Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism.
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism.
###end article-title 91
###begin article-title 92
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
###end article-title 92
###begin article-title 93
Dietary intake of antioxidants and risk of age-related macular degeneration.
###end article-title 93
###begin article-title 94
Scavenger receptor class B type I polymorphisms and peripheral arterial disease.
###end article-title 94
###begin article-title 95
###xml 24 29 <span type="species:ncbi:9606">human</span>
Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations.
###end article-title 95
###begin article-title 96
Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population.
###end article-title 96
###begin article-title 97
Population-based study of SR-BI genetic variation and lipid profile.
###end article-title 97
###begin article-title 98
###xml 114 117 <span type="species:ncbi:9606">men</span>
Scavenger receptor class B type I (SCARB1) c.1119C>T polymorphism affects postprandial triglyceride metabolism in men.
###end article-title 98
###begin article-title 99
###xml 105 110 <span type="species:ncbi:9606">women</span>
Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women.
###end article-title 99
###begin article-title 100
The genetics of age-related macular degeneration: a review of progress to date.
###end article-title 100
###begin article-title 101
Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism.
###end article-title 101
###begin article-title 102
A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors.
###end article-title 102
###begin article-title 103
A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.
###end article-title 103
###begin article-title 104
Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.
###end article-title 104
###begin article-title 105
Do age-related macular degeneration and cardiovascular disease share common antecedents?
###end article-title 105
###begin article-title 106
###xml 94 99 <span type="species:ncbi:9606">Women</span>
Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study.
###end article-title 106
###begin article-title 107
Age-related macular degeneration and mortality from cardiovascular disease or stroke.
###end article-title 107
###begin article-title 108
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human retinal pigment epithelial cells express scavenger receptors BI and BII.
###end article-title 108
###begin article-title 109
ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression.
###end article-title 109
###begin article-title 110
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse.
###end article-title 110
###begin article-title 111
Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI).
###end article-title 111
###begin article-title 112
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.
###end article-title 112
###begin article-title 113
Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA.
###end article-title 113
###begin article-title 114
Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese.
###end article-title 114
###begin article-title 115
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.
###end article-title 115
###begin p 116
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 116
###begin p 117
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by a French National Grant, from the ministary of Health (PHRC National 2004, from the Fondation pour la Recherche Medicale and the Association DMLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 117

